infographic
PKI Combo™ addresses the goals of both in vivo PK screening and metabolite profiling early, rapidly and economically. The key success of this service is to integrate, previously unrelated, discovery DMPK studies into one lab, using one animal study, one analytical instrument, and one study team.
Register to gain access to gated resources.
"*" indicates required fields
Frontage Laboratories websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies, and their use, please see our privacy policy.
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
